📊 DETAILS
Sector: Pharmaceuticals & Drugs
Mkt Cap: 21,545 cr
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership
position in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (incl High Potent APIs), Cardiovascular, and Gastro therapeutics. They also...
Laurus Lab Cmp 415 dated 22-12-2023
1. Ascending Triangle BO @ 403 (done)
2. Price Rise with Volume Rise
Buy @Cmp target 430-440-450-455-465-475 SL 390
It is just a view, please trade at your own risk.
My outlook on Laurus Labs Ltd
CMP AT 414
Inside Monthly CPR indicating a strong breakout on upside.
Candles are sustained above the monthly cpr and monthly resistance showing bullishness.
pattern breakout with good volume
#Lauruslabs #BREAKOUTSTOCKS
This is 1 years old Year Breakout
Keep a watch coming days on how the price moves. A strong day closing above 430 will be a good sign.
This idea is for Educational Purpose Only.
Learn & Earn,
LETS GROW TOGETHER
Faisal Merchant
I am not SEBI registered and all Ideas posted by me are for Educational Purpose.
Disclaimer: Iam not sebi registered, trade at your own risk take your financial advisor for buy sell recommendation, this is ony for educational purpose.
📈 Exciting Bullish Pattern Alert! 🐂
📊 Pattern: Descending Triangle
📌 Symbol/Asset: LAURUSLABS
🔍 Description: Stock has made one base and forming descending triangle pattern. It will give good move below breakdown of base and above breakout of resistance.
👉 Disclosure: We are not SEBI registered analysts, this is not a buy or sell recommendation. Technical...
got too much overbought in May 2021 and since then it's trying to cool down and consoildate
Until parallel channel is not breached. avoid entry
consolidation period may continue for next few months
LAURUS LAB is in tight consolidation after the 30SMA breakout. Q2 earning & FII & DII holding results are important as in Q1 FF increased stake at .10% and DII decreased by .26%.
